搜尋結果
Lilly Loses $120 Billion in Value as Rival Obesity Drugs Impress
Bloomberg· 1 日前Have a confidential tip for our reporters? Eli Lilly & Co. is down more than $120 billion in
Walmart To Expand Specialty Pharmacy Business
Forbes· 2 日前The nation’s largest retailer, which has long had traditional pharmacies in its stores, Thursday said ...
Indian Billionaire Brothers’ Mankind Pharma To Buy Bharat Serums For $1.6 Billion
Forbes· 22 小時前Serums and Vaccines (BSV) for 136.3 billion rupees ($1.6 billion) from Boston-based private ...
Sabotage Snarls French Trains as Olympics Begin - What’s News - WSJ Podcasts
The Wall Street Journal· 17 小時前Speaker 2: There are 250,000 travelers who are currently impacted, and that figure will rise to 800,000 by the& ...
US drug industry middlemen defend business model amid accusations of raising patient costs
Reuters· 2 日前U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a .. ...
Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
CNBC· 3 日前The treatment for hemophilia A could become the company's second ...
Venezuelans abroad say they are struggling to register to vote
Reuters· 16 小時前Voter advocacy groups pointed to problems ranging from closed consulates to requests for varied ...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 日前QuantumPharm, KPJ Healthcare and more in the latest Market Talks covering the Health Care ...
Will Pfizer Stock Post A Downbeat Q2?
Forbes· 22 小時前Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. The
Unsafe Ozempic Knockoffs Are Flooding the Market
Bloomberg· 5 日前The first dose of a copycat weight-loss drug Lindsay Posey took ...